Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
"New valproate regulations, informed choice and seizure risk"
We dont just provide a service
Who Should Not Use These Peptides
Here's what you need to know: Medicare Coverage (Effective Mid-2026) Following the November 2025 Trump administration agreements, Medicare will cover GLP-1 medications for obesity with: $50 monthly copay for eligible patients $245 government cost (down from $1,000+ list prices) Medicare Eligibility Requirements: BMI over 27 with prediabetes OR established cardiovascular disease, OR BMI over 30 with uncontrolled hypertension, kidney disease, or heart failure, OR BMI over 35 (severe obesity) Medicaid Coverage States can opt into $245 monthly pricing for all covered uses
Forced molecule switching
US$ 21.62
US$ 20.62
US$ 20.55
US$ 22.43
